High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis.
about
Multidimensional Roles of Collagen Triple Helix Repeat Containing 1 (CTHRC1) in Malignant CancersHigh expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer.Relevance of HLA-DP/DQ and ICAM-1 SNPs among Ovarian Cancer PatientsGene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.Elevated expression of CTHRC1 predicts unfavorable prognosis in patients with pancreatic ductal adenocarcinomaKIAA0101, a target gene of miR-429, enhances migration and chemoresistance of epithelial ovarian cancer cells.Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathwayCollagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.miR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-3β-involved Wnt/β-catenin signaling.Collagen triple helix repeat containing 1 promotes tumor angiogenesis in gastrointestinal stromal tumors.CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9.Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway
P2860
Q28075715-E4CEEF63-265E-442E-87E7-B81100CFFC05Q33827629-1E0D6928-6662-480D-8751-9E25539740FEQ33896545-416EBA1F-8110-4825-B89A-8E8BA766D7CAQ36928288-25B242C9-9D6D-4C6F-B955-EB4D8FF8A8EBQ37046800-33C9ACA6-B374-4592-8040-445B8B66883BQ37215557-D062D936-C001-4B4A-B380-60C8655B4189Q37286094-A8F68245-C75A-488F-B1EC-036751EE2B10Q37701508-E07CF25C-3D55-4F4E-95C4-9A8B5C5B871AQ42375241-71C97274-E43F-4DF3-80DC-5E0A345AF9DFQ47300446-A6F8B252-55C6-4C57-9D01-657503E9B324Q48533249-0DBD200D-C279-432C-92F6-B14DE0831892Q52598238-F3548D7A-2D51-459C-85C7-5BD37E12F1ECQ57067452-9421E04B-07B9-4781-A5FE-E3A1DEA69515
P2860
High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
High expression of CTHRC1 prom ...... ssociated with poor prognosis.
@ast
High expression of CTHRC1 prom ...... ssociated with poor prognosis.
@en
type
label
High expression of CTHRC1 prom ...... ssociated with poor prognosis.
@ast
High expression of CTHRC1 prom ...... ssociated with poor prognosis.
@en
prefLabel
High expression of CTHRC1 prom ...... ssociated with poor prognosis.
@ast
High expression of CTHRC1 prom ...... ssociated with poor prognosis.
@en
P2093
P2860
P356
P1433
P1476
High expression of CTHRC1 prom ...... ssociated with poor prognosis.
@en
P2093
Chongjin Feng
Hongwei Shen
Liantang Wang
Millicent Lin
Minzhi Hou
Shanyang He
Yang Zhang
Yunping Pan
Zhiqiang Cheng
P2860
P304
35813-35829
P356
10.18632/ONCOTARGET.5358
P407
P50
P577
2015-10-03T00:00:00Z